Medical experts have decried the skyrocketing cost and unavailability of diabetes medications in the country. This was even ...

Rybelsus: Novo Nordisk’s name-brand version of oral semaglutide tablets to help improve blood sugar levels (along with diet ...

An estimated 828 million adults (420 women, 408 men) had diabetes in 2022, an increase of 630 million since 1990. India (212 ...

Insulin production is dominated by the US’s Eli Lilly and Europe’s Sanofi and Novo Nordisk. All three pharmaceutical ...

Historically, patients diagnosed with type 2 diabetes mellitus have been treated with oral metformin, ideally accompanied by a healthy diet and exercise ... and pharmacy. Sanofi has taken a ...

Today, Sanofi and Breakthrough T1D UK announce a special collaboration with Beano, to mark World Diabetes Day, 14th November ...

A new alliance between Sanofi and Google has been launched to improve care in people with type 1 and type 2 diabetes, the latest in a growing number of tie-ups between pharma and technology companies.

Doctors Without Borders (MSF) is calling on Eli Lilly, Novo Nordisk and Sanofi to immediately reduce the price of insulin ...

There’s a new Muse in town. Sanofi, Formation Bio and OpenAI have joined forces to build an AI-powered tool designed to improve drug development by speeding up clinical trial recruitment.

Sanofi (Symbol: SNY) presently has an above average rank, in the top 50% of the coverage universe, which suggests it is among the top most "interesting" ideas that merit further research by investors.

A new study has found that Mounjaro may not only be good at treating diabetes, but could actually help prevent the disease.

New research shows that weight loss medications can stop the progression of prediabetes. Experts don’t all agree on such a ...